0001410384-20-000179.txt : 20201210 0001410384-20-000179.hdr.sgml : 20201210 20201210165053 ACCESSION NUMBER: 0001410384-20-000179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201208 FILED AS OF DATE: 20201210 DATE AS OF CHANGE: 20201210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Breeden John E CENTRAL INDEX KEY: 0001597609 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36350 FILM NUMBER: 201381181 MAIL ADDRESS: STREET 1: 13785 RESEARCH BLVD. STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78750 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Q2 Holdings, Inc. CENTRAL INDEX KEY: 0001410384 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 202706637 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 150 CITY: Austin STATE: TX ZIP: 78750 BUSINESS PHONE: 512-275-0072 MAIL ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 150 CITY: Austin STATE: TX ZIP: 78750 FORMER COMPANY: FORMER CONFORMED NAME: CBG Holdings, Inc. DATE OF NAME CHANGE: 20120103 FORMER COMPANY: FORMER CONFORMED NAME: CBG Holdings Inc DATE OF NAME CHANGE: 20070821 4 1 wf-form4_160763704034409.xml FORM 4 X0306 4 2020-12-08 0 0001410384 Q2 Holdings, Inc. QTWO 0001597609 Breeden John E 13785 RESEARCH BLVD. SUITE 150 AUSTIN TX 78750 0 1 0 0 Chief Operating Officer Common Stock 2020-12-08 4 M 0 1580 19.26 A 66160 D Common Stock 2020-12-08 4 M 0 1943 35.80 A 68103 D Common Stock 2020-12-08 4 F 0 873 114.73 D 67230 D Stock Option (right to buy) 19.26 2020-12-08 4 M 0 1580 0 D 2017-02-16 2023-02-16 Common Stock 1580.0 0 D Stock Option (right to buy) 35.8 2020-12-08 4 M 0 1943 0 D 2018-02-21 2024-02-21 Common Stock 1943.0 25397 D This option grant vested as to 1/4 of the total option grant on February 16, 2017, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. This option grant vested as to 1/4 of the total option grant on February 21, 2018, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests. /s/ M. Scott Kerr, attorney-in-fact 2020-12-09